For help on how to get the results you want, see our search tips.
281 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Shortages Remove Shortages filter
Withdrawn applications Remove Withdrawn applications filter
Medicine type
Generic Remove Generic filter
-
List item
Human medicine European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka) (updated)
irbesartan hydrochloride, Hypertension
Date of authorisation: 01/12/2008,
, Revision: 14, Authorised, Last updated: 03/08/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya) (updated)
clopidogrel (as hydrochloride),
Date of authorisation: 20/09/2009,, Revision: 12, Authorised, Last updated: 30/07/2021
-
List item
Human medicine European public assessment report (EPAR): Mysildecard (updated)
sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 15/09/2016,, Revision: 4, Authorised, Last updated: 30/07/2021
-
List item
Human medicine European public assessment report (EPAR): Azacitidine Accord (updated)
azacitidine, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
Date of authorisation: 13/02/2020,, Revision: 2, Authorised, Last updated: 29/07/2021
-
List item
Human medicine European public assessment report (EPAR): Matever (updated)
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 23, Authorised, Last updated: 29/07/2021
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited) (updated)
pemetrexed ditromethamine, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 24/04/2017,, Revision: 7, Withdrawn, Last updated: 29/07/2021
-
List item
Human medicine European public assessment report (EPAR): Lenalidomide Mylan (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 18/12/2020,, Revision: 2, Authorised, Last updated: 26/07/2021
-
List item
Human medicine European public assessment report (EPAR): Tadalafil Mylan (updated)
tadalafil, Erectile Dysfunction
Date of authorisation: 21/11/2014,, Revision: 12, Authorised, Last updated: 26/07/2021
-
List item
Human medicine European public assessment report (EPAR): Rasagiline Mylan (updated)
rasagiline tartrate, Parkinson Disease
Date of authorisation: 04/04/2016,, Revision: 4, Authorised, Last updated: 23/07/2021
-
List item
Human medicine European public assessment report (EPAR): Tenofovir disoproxil Zentiva (updated)
tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 15/09/2016,, Revision: 10, Authorised, Last updated: 22/07/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva (updated)
emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 09/11/2016,, Revision: 6, Authorised, Last updated: 21/07/2021
-
List item
Human medicine European public assessment report (EPAR): Apixaban Accord (updated)
Apixaban, Venous Thromboembolism, Stroke, Arthroplasty
Date of authorisation: 23/07/2020,, Revision: 1, Authorised, Last updated: 21/07/2021
-
List item
Human medicine European public assessment report (EPAR): Lamivudine/Zidovudine Teva (updated)
lamivudine, zidovudine, HIV Infections
Date of authorisation: 28/02/2011,, Revision: 13, Authorised, Last updated: 20/07/2021
-
List item
Human medicine European public assessment report (EPAR): Miglustat Dipharma (updated)
miglustat, Gaucher Disease
Date of authorisation: 18/02/2019,, Revision: 3, Authorised, Last updated: 20/07/2021
-
List item
Human medicine European public assessment report (EPAR): Striascan (updated)
ioflupane (123l), Radionuclide Imaging, Dementia, Movement Disorders
Date of authorisation: 25/06/2019,, Revision: 1, Authorised, Last updated: 16/07/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)
clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 13, Authorised, Last updated: 16/07/2021
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Hospira (updated)
levetiracetam, Epilepsy
Date of authorisation: 07/01/2014,, Revision: 18, Authorised, Last updated: 16/07/2021
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed Lilly (updated)
pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 14/09/2015,, Revision: 6, Authorised, Last updated: 14/07/2021
-
List item
Human medicine European public assessment report (EPAR): Deferiprone Lipomed (updated)
Deferiprone, Iron Overload, beta-Thalassemia
Date of authorisation: 19/09/2018,, Revision: 4, Authorised, Last updated: 13/07/2021
-
List item
Human medicine European public assessment report (EPAR): Ucedane (updated)
carglumic acid, Hyperammonemia, Amino Acid Metabolism, Inborn Errors
Date of authorisation: 23/06/2017,, Revision: 7, Authorised, Last updated: 13/07/2021
-
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva Pharma B.V. (updated)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 01/07/2009,, Revision: 14, Withdrawn, Last updated: 09/07/2021
-
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva (updated)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 31/03/2009,, Revision: 15, Withdrawn, Last updated: 09/07/2021
-
List item
Human medicine European public assessment report (EPAR): Irbesartan/Hydrochlorothiazide Teva (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 26/11/2009,, Revision: 19, Authorised, Last updated: 08/07/2021
-
List item
Human medicine European public assessment report (EPAR): Duloxetine Mylan (updated)
duloxetine, Neuralgia, Diabetic Neuropathies, Anxiety Disorders, Depressive Disorder, Major
Date of authorisation: 19/06/2015,, Revision: 14, Authorised, Last updated: 08/07/2021
-
List item
Human medicine European public assessment report (EPAR): Deferasirox Accord (updated)
deferasirox, Iron Overload, beta-Thalassemia
Date of authorisation: 09/01/2020,, Revision: 1, Authorised, Last updated: 08/07/2021